Fundz

Fundz Deep Dive

Everything you need to win Mitsubishi Tanabe Pharma Corporation — in one platform.

Who to reach, what to say, and why now on Mitsubishi Tanabe Pharma Corporation — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Mitsubishi Tanabe Pharma Corporation — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Bain Capital to Partner with Mitsubishi Tanabe Pharma Corporation for Significant Investment in Innovation

Feb 07, 2025•over 1 year ago

Contract Type

partnership

OsakaBiotechnologyHealth CarePharmaceutical

Description

Bain Capital has signed a definitive agreement to partner with Mitsubishi Tanabe Pharma Corporation (“Tanabe Pharma”) in a carve-out transaction from Mitsubishi Chemical Group Corporation. The partnership involves a significant investment in innovation, internal product development, and external licensing and acquisitions, valuing the business at approximately 510 billion JPY (3.3 billion USD). Tanabe Pharma, as an independent company, will benefit from the full support of Bain Capital’s global resources and healthcare team’s extensive experience in driving value creation across the healthcare value chain.

Company Information

Company

Mitsubishi Tanabe Pharma Corporation

Location

Osaka, Osaka Prefecture, Japan

About

Mitsubishi Tanabe Pharma Corporation (MTPC) is one of the oldest pharmaceutical companies in the world, founded in 1678. It is headquartered in Doshomachi, Osaka, Japan, and focuses on ethical pharmaceuticals with a mission of 'Creating hope for all facing illness'. MTPC is dedicated to the disease areas of central nervous system, immuno-inflammation, diabetes and kidney, and cancer.

Predictive Intelligence
Strategic

ML-powered predictions for Mitsubishi Tanabe Pharma Corporation's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.